OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Industry Outlook 2025: Personalizing Precision Medicine and Adopting AI
Pharmaceutical Technology® chatted with Preeya Beczek, managing director and co-founder of Beczek.COM, about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
“I do think there's a number of areas that are going to be trends for 2025 and somewhat continuation from this year,” says Preeya Beczek, managing director and co-founder of Beczek.COM Ltd, a specialist in regulatory affairs and compliance. “There's a real focus on personalizing precision medicine, including cell and gene therapies, and, you know, there's expected to be quite a major trend in this area to really focus on the personalized part of that.”
Additionally, there has been a lot of talk from industry about digital manufacturing and using cloud-based systems to improve efficiency, Beczek continues. And, going hand-in-hand with the data-driven approach is the ability for companies to realize the potential return on investment for their R&D efforts, she adds. “It's really looking at that end to end, moving away from functional silos to looking at the R&D end to end, which I find very exciting, actually, because it can really improve health outcomes and really allow companies to focus on the patient,” Beczek says.
A key trend for 2025 will be artificial intelligence (AI), Beczek specifies. “I think we're just going to have lot more people adopting [Generative AI and] that way of working, in their day-to-day work,” she says. “I think that there's going to be some push to get speed, [in] things like manufacturing timelines, [so] they become shorter.”
Click above to watch the full interview
About the speaker
Preeya Beczek is Managing Director and Co-Founder of Beczek.COM Ltd, a specialist in regulatory affairs and compliance. Preeya has worked in the regulatory affairs and compliance space for over 25 years, focusing on regulatory affairs activities at a strategic and operational level. Prior to her current role, Preeya worked in industry performing a lot of infrastructure and process development to support companies with new systems, initiatives with AI automation, regulatory, information management, system software modernization, and so on.
